Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,800 shares at $159.51 ($4.7M) on 2021-03-12, disclosed to the SEC on 2021-03-16.
Open-market sale of $4.7M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.52 | 2,100 | $324K | 6.9% |
| 2 | $155.54 | 3,807 | $592K | 12.7% |
| 3 | $155.54 | 3,807 | $592K | 12.7% |
| 4 | $156.52 | 3,606 | $564K | 12.1% |
| 5 | $156.52 | 3,606 | $564K | 12.1% |
| 6 | $157.70 | 2,211 |
| $349K |
| 7.5% |
| 7 | $157.70 | 2,211 | $349K | 7.5% |
| 8 | $158.85 | 3,176 | $505K | 10.8% |
| 9 | $158.85 | 3,176 | $505K | 10.8% |
| 10 | $159.51 | 2,100 | $335K | 7.2% |
| Total | $157.01 avg | 29,800 | $4.7M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |